Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

• প্রধান লেখক: Milana Bergamino Sirvén (লেখক), Adela Fernández-Ortega (লেখক), Agostina Stradella (লেখক), Idoia Morilla (লেখক), Catalina Falo (লেখক), Silvia Vázquez (লেখক), Roser Castany (লেখক), Rafael Villanueva (লেখক), Sabela Recalde (লেখক), Valentí Navarro Pérez (লেখক), Miguel Gil-Gil (লেখক), Sonia Pernas (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2019-11-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Eribulin improves survival in pre-treated HER2-negative advanced breast cancer (ABC). However, limited data exist on co-morbidities and central nervous system (CNS) efficacy. The purpose of this study was to review eribulin's efficacy and safety in everyday clinical practice...